Anthrax countermeasures get US liability protection
This article was originally published in Scrip
Executive Summary
Companies that develop and manufacture medical anthrax countermeasures will receive immunity from product liability claims through 2015 under a declaration issued by the US health and human services secretary Michael Leavitt.